Friday, 20 November 2026

North America

Neurotronics Secures FDA Clearance for AI-Based Sleep Analysis Module

Software-only device estimates total sleep time from an existing pulse oximetry signal, providing additional clinical information without requiring an additional sensor...

SYMPHONY-PE Analysis Highlights Safety and Efficacy of Thrombectomy in Women

The analysis found that women and men with intermediate-risk pulmonary embolism (PE) experienced substantial clot burden reduction, improvements in right-heart function...

Zyndio and DEXASCAN Collaborate to Connect Body Composition Testing With Physician-Led Care

Proposed model links DEXA measurements, clinical evaluation and ongoing monitoring to inform preventive care...

LINK announces full U.S. commercial launch of ALLURE triple-tapered hip stem

Available in collared and collarless configurations, ALLURE expands LINK’s primary hip portfolio ahead of the 2026 AAHKS Annual Meeting...

CereVasc Receives FDA IDE Approval to Evaluate eShunt System in Patients with Alzheimer's Disease

FDA authorization enables clinical investigation of a fundamentally different approach for patients with early symptomatic Alzheimer's disease...

Abbott Initiates Pivotal CROWN-MV Trial of Investigational Cephea Mitral Valve System

CROWN-MV trial will evaluate the safety and effectiveness of the investigational Cephea mitral valve replacement device...

Mezoo: The Wonju Wearable Taking Patient Monitoring Beyond the Bedside

Born in Wonju's medical device cluster, Mezoo has turned a credit-card-sized chest patch into a monitoring platform used in more than 700 Korean hospitals and clinics. Fresh from a strong KOSDAQ debut and with approvals in nine countries, the company is now taking its HiCardi system to the world...

Joe DiMaggio Children's Hospital Expands Care for Teens with Down Syndrome

Hospital to become the only center in South Florida offering Inspire therapy for pediatric patients with Down syndrome and obstructive sleep apnea...

HOPPR expands medical imaging AI portfolio with whole-body musculoskeletal X-ray narrative model

Beta model generates draft findings from up to three radiographic views and is available for evaluation rather than diagnostic use...

SetPoint Medical Treats First Boston Patient with FDA-Approved Neuroimmune Modulation System for Rheumatoid Arthritis

Only FDA-approved neuroimmune modulation therapy for rheumatoid arthritis is now available to adults throughout New England...